Walton Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 6.42 M
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 32.64%
- Profit Growth 30.68%
- Ebitda 133.24%
- Net Worth 2.08%
- Total Assets 13.34%
About Walton Lifesciences
Walton Lifesciences Private Limited (WLPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 November 2011 and has a history of 13 years and two months. Its registered office is in Salem, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 6.42 M, as per Ministry of Corporate Affairs (MCA) records.
Dhanalakshmi Mahadevan, Radhakrishnan Gopalakrishnan, and Radhakrishnan Srinivasan serve as directors at the Company.
Company Details
-
Location
Salem, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TZ2011PTC017616
-
Company No.
017616
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Nov 2011
-
Date of AGM
08 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Walton Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhanalakshmi Mahadevan
|
Director | 24-Nov-2011 | Current |
|
Radhakrishnan Gopalakrishnan
|
Director | 24-Nov-2011 | Current |
|
Radhakrishnan Srinivasan
|
Director | 04-Jan-2019 | Current |
Financial Performance of Walton Lifesciences.
Walton Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.64% increase. The company also saw a substantial improvement in profitability, with a 30.68% increase in profit. The company's net worth moved up by a moderate rise of 2.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walton Lifesciences?
In 2021, Walton Lifesciences had a promoter holding of 6.54% and a public holding of 93.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Walton Health Care Private LimitedRadhakrishnan Gopalakrishnan and Radhakrishnan Srinivasan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Walton Lifesciences?
Walton Lifesciences has a workforce of 8 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walton Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walton Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
